Refractory Wounds clinical trials

Explore recruiting refractory wounds clinical trials.

Recruiting refractory wounds studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Wounds trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A two-part study: open label, dose escalation phase aimed to evaluate the safety and tolerability of two different doses of allogeneic fibroblasts for the treatment of chronic refractory wounds and identifying the best dose for subsequent cohort expansion phase aimed to assess efficacy and confirm safety and tolerability

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Refractory Wounds trials by city

Refractory Wounds in Toronto Refractory Wounds in Vancouver Refractory Wounds in Montreal Refractory Wounds in Calgary Refractory Wounds in Edmonton Refractory Wounds in Ottawa Refractory Wounds in Winnipeg Refractory Wounds in Quebec City Refractory Wounds in Hamilton Refractory Wounds in Kitchener Refractory Wounds in London Refractory Wounds in Halifax Refractory Wounds in New York Refractory Wounds in Los Angeles Refractory Wounds in Chicago Refractory Wounds in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease